Filing Details
- Accession Number:
- 0001104659-25-025194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 19:07:35
- Reporting Period:
- 2025-03-14
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 19:07:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247309 | Robert Stefanovich | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-14 | 10,000 | $0.00 | 193,078 | No | 4 | A | Direct | |
Common Stock | Disposition | 2025-03-17 | 1,659 | $6.29 | 191,419 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2025-03-14 | 25,000 | $0.00 | 25,000 | $7.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2032-03-14 | No | 4 | A | Direct |
Footnotes
- Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.
- Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.